These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23253484)

  • 1. In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A.
    de Azevedo M; Karczewski J; Lefévre F; Azevedo V; Miyoshi A; Wells JM; Langella P; Chatel JM
    BMC Microbiol; 2012 Dec; 12():299. PubMed ID: 23253484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response elicited by DNA vaccination using Lactococcus lactis is modified by the production of surface exposed pathogenic protein.
    Pontes D; Azevedo M; Innocentin S; Blugeon S; Lefévre F; Azevedo V; Miyoshi A; Courtin P; Chapot-Chartier MP; Langella P; Chatel JM
    PLoS One; 2014; 9(1):e84509. PubMed ID: 24465412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of Fibronectin Binding Protein A at the surface of Lactococcus lactis increases plasmid transfer in vitro and in vivo.
    Pontes D; Innocentin S; Del Carmen S; Almeida JF; Leblanc JG; de Moreno de Leblanc A; Blugeon S; Cherbuy C; Lefèvre F; Azevedo V; Miyoshi A; Langella P; Chatel JM
    PLoS One; 2012; 7(9):e44892. PubMed ID: 23028664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant invasive Lactococcus lactis can transfer DNA vaccines either directly to dendritic cells or across an epithelial cell monolayer.
    de Azevedo M; Meijerink M; Taverne N; Pereira VB; LeBlanc JG; Azevedo V; Miyoshi A; Langella P; Wells JM; Chatel JM
    Vaccine; 2015 Sep; 33(38):4807-12. PubMed ID: 26241952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells.
    Innocentin S; Guimarães V; Miyoshi A; Azevedo V; Langella P; Chatel JM; Lefèvre F
    Appl Environ Microbiol; 2009 Jul; 75(14):4870-8. PubMed ID: 19482952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells.
    Guimarães VD; Innocentin S; Lefèvre F; Azevedo V; Wal JM; Langella P; Chatel JM
    Appl Environ Microbiol; 2006 Nov; 72(11):7091-7. PubMed ID: 16963550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual recombinant Lactococcus lactis for enhanced delivery of DNA vaccine reporter plasmid pPERDBY.
    Yagnik B; Sharma D; Padh H; Desai P
    Microbiol Immunol; 2017 Apr; 61(3-4):123-129. PubMed ID: 28258689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peyer's Patches as a Portal for DNA Delivery by Lactococcus lactis in Vivo.
    Yano A; Takahashi K; Mori Y; Watanabe S; Hanamura Y; Sugiyama T; Inoue N
    Biol Pharm Bull; 2018; 41(2):190-197. PubMed ID: 29386479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internalin-expressing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cells.
    Guimarães VD; Gabriel JE; Lefèvre F; Cabanes D; Gruss A; Cossart P; Azevedo V; Langella P
    Microbes Infect; 2005 May; 7(5-6):836-44. PubMed ID: 15878681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of fibronectin binding protein A (FnBPA) from Staphylococcus aureus at the cell surface of Lactococcus lactis improves its immunomodulatory properties when used as protein delivery vector.
    Almeida JF; Breyner NM; Mahi M; Ahmed B; Benbouziane B; Boas PC; Miyoshi A; Azevedo V; Langella P; Bermúdez-Humarán LG; Chatel JM
    Vaccine; 2016 Mar; 34(10):1312-8. PubMed ID: 26854905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective uses of recombinant Lactococcus lactis expressing both listeriolysin O and mutated internalin A from Listeria monocytogenes as a tool for DNA vaccination.
    De Azevedo MS; Santos Rocha C; Pereira VB; De Oliveira Junior AF; De Sousa CS; Azevedo V; LeBlanc JG; Chatel JM; Miyoshi A
    Genet Mol Res; 2015 Dec; 14(4):18485-93. PubMed ID: 26782496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between fibronectin binding protein A expression level at the surface of recombinant lactococcus lactis and plasmid transfer in vitro and in vivo.
    Almeida JF; Mariat D; Azevedo V; Miyoshi A; de Moreno de LeBlanc A; Del Carmen S; Martin R; Langella P; LeBlanc JG; Chatel JM
    BMC Microbiol; 2014 Sep; 14():248. PubMed ID: 25249337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin.
    Chatel JM; Langella P; Adel-Patient K; Commissaire J; Wal JM; Corthier G
    Clin Diagn Lab Immunol; 2001 May; 8(3):545-51. PubMed ID: 11329455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed evolution and targeted mutagenesis to murinize Listeria monocytogenes internalin A for enhanced infectivity in the murine oral infection model.
    Monk IR; Casey PG; Hill C; Gahan CG
    BMC Microbiol; 2010 Dec; 10():318. PubMed ID: 21144051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization.
    Adel-Patient K; Ah-Leung S; Creminon C; Nouaille S; Chatel JM; Langella P; Wal JM
    Clin Exp Allergy; 2005 Apr; 35(4):539-46. PubMed ID: 15836765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergy therapy by intranasal administration with recombinant Lactococcus lactis Producing bovine beta-lactoglobulin.
    Cortes-Perez NG; Ah-Leung S; Bermúdez-Humarán LG; Corthier G; Langella P; Wal JM; Adel-Patient K
    Int Arch Allergy Immunol; 2009; 150(1):25-31. PubMed ID: 19339799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a new DNA vaccine based on mycobacterial ESAT-6 antigen delivered by recombinant invasive Lactococcus lactis FnBPA+.
    Pereira VB; Saraiva TD; Souza BM; Zurita-Turk M; Azevedo MS; De Castro CP; Mancha-Agresti P; Dos Santos JS; Santos AC; Faria AM; Leclercq S; Azevedo V; Miyoshi A
    Appl Microbiol Biotechnol; 2015 Feb; 99(4):1817-26. PubMed ID: 25503506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive Lactococcus lactis producing mycobacterial Hsp65 ameliorates intestinal inflammation in acute TNBS-induced colitis in mice by increasing the levels of the cytokine IL-10 and secretory IgA.
    da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
    J Appl Microbiol; 2020 Nov; 129(5):1389-1401. PubMed ID: 32473073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a new shuttle vector for DNA delivery into mammalian cells using non-invasive Lactococcus lactis.
    Yagnik B; Padh H; Desai P
    Microbes Infect; 2016 Apr; 18(4):237-44. PubMed ID: 26655884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a Lactococcus lactis ΔpyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes.
    Bahey-El-Din M; Casey PG; Griffin BT; Gahan CG
    Bioeng Bugs; 2010; 1(1):66-74. PubMed ID: 21327128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.